About US
Contact us
-
Sanofi-aventis receives FDA approval for new Taxotere Injection Concentrate formulationSanofi-aventis U.S. announced today that the U.S. Food and Drug Administration (FDA) has approved a new one-vial formulation of its chemotherapeutic agent Taxotere® (docetaxel) Injection Concentra2010/8/6
-
BASF raises prices for isophorone diamine in EuropeBASF is raising its prices for isophorone diamine (IPDA) in Europe by €200 per metric ton, or by the corresponding amount in local currency, effective immediately or as existing contracts permit.2010/8/5
-
BASF declares Force Majeure on Plastomoll® DNA, Palatinol® N, Hexamoll® DINCH and selected Palamoll®gradesLudwigshafen , Germany – July 21, 2010 – Due to a shortage of raw materials caused by an unforeseeable technical defect in its iso-Nonanol (INA) plant in Ludwigshafen, Germany, BASF SEis currently una2010/8/5
-
Victory Pharma acquires assets of MiddleBrook PharmaceuticalsVictory Pharma, Inc. ("Victory") today announced that it has completed the acquisition of substantially all of the assets of MiddleBrook Pharmaceuticals, Inc. (OTCQB: MBRKQ). Through the acquisition,2010/8/5
-
SFDA issues measures on management of health food and cosmetic evaluation expertsIn order to further intensify the review of health food and cosmetics, standardize the management of the evaluation experts, and ensure that the registration of health food and cosmetics is scientif2010/8/4
-
WHO Director-General Dr Margaret Chan visits NICPBPOn July 27, 2010, Dr Margaret Chan, Director-General of the World Health Organization (WHO) and her entourage visited National Institute for the Control of Pharmaceutical and Biological Products (NI2010/8/4
-
Xeomin receives FDA approval for treatment of cervical dystoniaMerz Pharmaceuticals today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Xeomin® (incobotulinumtoxinA), a botulinum toxin type A for the treatment of adul2010/8/4
-
Senate panel votes to end drug industry's practice of 'pay-to-delay' genericsThe Associated Press: "In a defeat for the powerful drug lobby, a Senate panel approved legislation to prohibit drug companies from paying generic drug makers to delay bringing less costly products to2010/8/2
-
FDA announces approval of vaccines for 2010-2011 US influenza seasonThe U.S. Food and Drug Administration announced today that it has approved vaccines for the 2010-2011 influenza season in the United States. Seasonal influenza vaccine protects against three strains2010/8/2
-
FDA Advisory Committee recommends approval of AstraZeneca's ticagrelor for Acute Coronary SyndromesAstraZeneca (NYSE: AZN) today announced that the US Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee recommended the FDA approve AstraZeneca's investigational drug2010/7/30